Ryotaro Sakamori
0000-0002-1580-607X
Osaka National Hospital
281 papers found
Refreshing results…
Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions
Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway
Hepatocellular carcinoma occurrence does not differ between interferon‐based and interferon‐free treatment with liver histological assessment
Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice
Improvement in Serum Albumin Levels After Direct-Acting Antivirals Treatment for Patients With Hepatitis C Virus-Related Cirrhosis Depends on the Baseline Serum Albumin Levels
NOVEL ANTI-HBV THERAPIES USING CRISPR/Cas9 TARGETING HBV GENOME STRONGLY SUPPRESS HBV
INACTIVATION OF Traf3 PROMOTED DEVELOPMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA VIA HEPATOCYTE TRANSDIFFERENTIATION IN MICE
Identification and Functional Analysis of Ube2d3, a Novel Tumor Suppressor Gene of Hepatocellular Carcinoma
Gdf15 Secreted by Hepatic Stellate Cells Accelerates HCC Progression in an Autophagy-Dependent Manner
Orchestration of Bh3-Only Proteins Bim, Bid, Puma and Noxa Controls Bak/Bax Dependent Hepatocyte Apoptosis
OVER-ACTIVATION OF TUMOR SUPPRESSOR P53 IN HEPATOCYTES PARADOXICALLY PROMOTES HEPATOCARCINOGENESIS DERIVED FROM HEPATIC PROGENITOR CELLS
Therapeutic Efficacy of Lenvatinib Associated With Advanced Portal Hypertension in Unresectable Hepatocellular Carcinoma Patients With Low-Relative Dose Intensity or With Poor Liver Function
Baseline Platelet Count Predicts the Occurrence of Decompensated Events in Patients With Hepatitis C-Related Compensated Cirrhosis Who Achieved Sustained Virologic Response
Serum St6gal1 Is a Novel Biomarker for Predicting Efficacy of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma
ACTIVATION OF P53 AFTER RADIATION IMPAIRS THE REGENERATIVE CAPACITY OF THE LIVER
Molecular and Immunological Profiling of Non-Viral Hepatocellular Carcinoma Through Multi-Omics Approach
Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma
Remaining challenges for the noninvasive diagnosis of esophageal varices in liver cirrhosis
CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
Soluble UL16-binding protein 2 is associated with a poor prognosis in pancreatic cancer patients
Missing publications? Search for publications with a matching author name.